TY - JOUR
T1 - Total Knee Arthroplasty Is Safe and Successful in Patients With Klippel-Trénaunay Syndrome
AU - Labott, Joshua R.
AU - Wyles, Cody C.
AU - Houdek, Matthew T.
AU - Tollefson, Megha M.
AU - Driscoll, David J.
AU - Shaughnessy, William J.
AU - Sierra, Rafael
PY - 2019/4/1
Y1 - 2019/4/1
N2 - Background: Klippel-Trénaunay syndrome (KTS) is a severe vascular malformation that can lead to hypertrophic osteoarthritis. Total knee arthroplasty (TKA) performed in extremities affected with KTS is challenging given the high-risk vascular considerations and occasionally poor bone quality. Methods: We identified 12 patients with KTS who underwent TKA between 1998 and 2017. There were 7 men, mean age 42 years, and mean follow-up was 7 years. Before arthroplasty, 2 patients (17%) had preoperative sclerotherapy. Preoperative vascular studies were done for 9 patients (75%) and included magnetic resonance imaging (n = 7), magnetic resonance angiography (n = 1), and computed tomography angiography (n = 1). A preoperative blood conservation protocol was used for all operations and included the use of tranexamic acid (TXA) in later years. Posterior-stabilized TKA was used in 10 cases and cruciate-retaining TKA was used in 2 cases. Results: At final follow-up, 2 patients (17%) had undergone revision surgery: 1 for infection and 1 for tibial loosening with subsequent arthrofibrosis. Knee Society Scores (36-83, P <.0001) and functional scores (48-84, P =.0007) significantly increased between the preoperative and postoperative period. Likewise at last follow-up, the mean knee range of motion significantly increased (82°-104°, P =.04). Median blood loss for patients who received TXA was 200 mL compared to 275 mL in patients who did not receive TXA (P =.66). Likewise there was no difference (P =.5) in the proportion of patients who required a transfusion between those who received TXA (2/6, 33%) and those who did not (3/6, 50%). Conclusion: In this small series, TKA can lead to significant clinical improvement for patients with KTS. Modern blood management techniques and a careful multidisciplinary care approach render TKA a reasonable option for select patients with KTS. Level of Evidence: Level IV case series, therapeutic.
AB - Background: Klippel-Trénaunay syndrome (KTS) is a severe vascular malformation that can lead to hypertrophic osteoarthritis. Total knee arthroplasty (TKA) performed in extremities affected with KTS is challenging given the high-risk vascular considerations and occasionally poor bone quality. Methods: We identified 12 patients with KTS who underwent TKA between 1998 and 2017. There were 7 men, mean age 42 years, and mean follow-up was 7 years. Before arthroplasty, 2 patients (17%) had preoperative sclerotherapy. Preoperative vascular studies were done for 9 patients (75%) and included magnetic resonance imaging (n = 7), magnetic resonance angiography (n = 1), and computed tomography angiography (n = 1). A preoperative blood conservation protocol was used for all operations and included the use of tranexamic acid (TXA) in later years. Posterior-stabilized TKA was used in 10 cases and cruciate-retaining TKA was used in 2 cases. Results: At final follow-up, 2 patients (17%) had undergone revision surgery: 1 for infection and 1 for tibial loosening with subsequent arthrofibrosis. Knee Society Scores (36-83, P <.0001) and functional scores (48-84, P =.0007) significantly increased between the preoperative and postoperative period. Likewise at last follow-up, the mean knee range of motion significantly increased (82°-104°, P =.04). Median blood loss for patients who received TXA was 200 mL compared to 275 mL in patients who did not receive TXA (P =.66). Likewise there was no difference (P =.5) in the proportion of patients who required a transfusion between those who received TXA (2/6, 33%) and those who did not (3/6, 50%). Conclusion: In this small series, TKA can lead to significant clinical improvement for patients with KTS. Modern blood management techniques and a careful multidisciplinary care approach render TKA a reasonable option for select patients with KTS. Level of Evidence: Level IV case series, therapeutic.
KW - blood management
KW - Klippel Trenaunay
KW - Klippel-Trénaunay syndrome
KW - total knee arthroplasty
KW - vascular malformations
UR - http://www.scopus.com/inward/record.url?scp=85060092208&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85060092208&partnerID=8YFLogxK
U2 - 10.1016/j.arth.2018.12.028
DO - 10.1016/j.arth.2018.12.028
M3 - Article
C2 - 30665834
AN - SCOPUS:85060092208
SN - 0883-5403
VL - 34
SP - 682
EP - 685
JO - Journal of Arthroplasty
JF - Journal of Arthroplasty
IS - 4
ER -